Hemp Industry Daily reports..

The largest-yet human CBD toxicological trial has been launched in Europe to check the effects of consuming trace amounts of THC.

The European Industrial Hemp Association says it will assess 200 CBD users for a 30-day period.

The association tells UK-based Cannabis Health News that the goal is to demonstrate to European regulators that trace THC is safe to consume. The effort will cost 1.6 million Euros ($1.9 million).

It’s been two years since EU authorities classified all hemp extracts and hemp-derived products containing CBD and other cannabinoids as “novel foods.”

The EIHA has bristled against the designation, which means that manufacturers need to have their CBD supplements and foods evaluated before getting permission from EU authorities to place them on the market.

More at  

 

Largest human CBD trial launches with eye toward checking safety of trace THC